The term "biobanking" is sometimes misused to refer to any collection of human biological materials (biospecimens), regardless of ethical or regulatory restrictions or the uniformity of various tissue collecting procedures. Large collections of biospecimens connected to important personal and health information (health records, family history, lifestyle, genetic information) are stored primarily for use in health and medical research, according to a suitable definition of biobanks. Furthermore, the International Organization for Standardization emphasizes the concept of biobanks as legal entities driving the acquisition and storage process, as well as some or all of the activities related to collection, preparation, preservation, testing, analysis, and distribution of defined biological material, as well as related information and data (ISO 20387:2018). It's impossible to identify all of a biobank's distinguishing characteristics because they all have diverse histories and goals. Furthermore, biobanks are concerned with the public good rather than individual rewards for participants, and seek to give a public benefit for future generations through the translation and application of research findings. It's critical to recognize that biological samples are "pseudonymized" rather than completely "anonymized"; this is crucial for providing feedback to sample owners, retrieving valuable information, and reuniting them with their specimens
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States